Global pharma cold chain logistics will grow from $18.6B to $27.11B by 2033, powered by biologics, IoT, AI, and supply chain policy shifts.
vital for transporting vaccines, biologics, and advanced therapies—ensures strict temperature compliance from manufacturing to patient delivery. According to DataM Intelligence analysis, the global market reached approximately USD 18.61 billion in 2024 and is projected to grow to USD 27.11 billion by 2033, achieving a CAGR of 4.3% over the period. This growth reflects escalating demand for temperature-sensitive therapies and the integration of smart logistics technologies.
